Enzymes, Microbial Strains, Contract Manufacturing

c-LEcta GmbH is a biotechnology company that specializes in the development and production of enzyme products tailored for the food and pharmaceutical industries. Utilizing advanced enzyme engineering and production technologies, c-LEcta provides innovative biotechnological solutions aimed at enhancing industrial applications. Their enzyme products are designed to improve food safety and production efficiency, as well as to support the development of new therapeutic forms in the pharmaceutical sector, including gene and cell therapies. The company operates under the Kerry Group and has established a reputation for delivering high-quality biotechnological products to over 400 customers worldwide.

Central to c-LEcta's operations is their proprietary ENESYZ technology platform, which enables the customization of enzymes and microbial production strains to meet diverse industrial needs. This platform has been continuously refined since its inception in 2004, boasting a high technical success rate in enzyme engineering projects. c-LEcta employs a range of production methods, including microbial fermentation and biocatalysis, utilizing various microorganisms such as Escherichia coli, Pichia pastoris, and Bacillus. Their state-of-the-art pilot plant is ISO 9001 and EXCiPACT certified, ensuring that their production processes adhere to stringent quality standards, which are crucial for both food and pharmaceutical applications.

Germany

c-LEcta is a global biotechnology company specializing in the development, production and distribution of enzyme products. The company uses world-class enzyme engineering and production technologies to provide its partners in the food and pharmaceutical industries with superior biotechnological solutions for innovative industrial applications. c-LEcta is part of the Kerry Group.

c-LEcta GmbH

Company Details